Transparency

For our daily readers, you may have seen our post yesterday about the Pharmaceutical and Research Manufacturers of America (PhRMA)…

The Court of Appeal for Ontario recently ruled that the public has a general right know the names of top billing doctors within…

Some of our readers may be familiar with Jose Baselga, MD, PhD, the former Physician-in-Chief at the Memorial Sloan Kettering…

Transparency is always a hot topic, and a recent tweet by Allan Coukell brought the issue to the forefront once again. The…

Recently, the United States Department of Health and Human Services Office of Inspector General (HHS OIG) completed a review of…

Recently, Rafael Fonseca, MD and John A. Tucker, MBA, PhD, issued a critical analysis of a recent study that drew correlations…

Price transparency has been a “buzz phrase” for the pharmaceutical industry for the last several years. However, the state of New…

Recently, Canadian news outlet The Globe and Mail reported that British Columbia is planning to join Ontario in requiring…

On Friday, June 29, 2018 the Centers for Medicare & Medicaid Services (“CMS”) released the 2017 Open Payments Data, which…

As the federal government continues talking on ways it could address drug costs for tomorrow, state legislatures are acting to…